Home Health Senate bill seeks to curb US reliance on China in drug industry
Health

Senate bill seeks to curb US reliance on China in drug industry

Senate bill seeks to curb US reliance on China in drug industry
Key Points

US lawmakers are pushing for more scrutiny of Chinese investment in pharmaceuticals and biotechnology, as Washington’s strategic competition with Beijing expands beyond semiconductors and artificial intelligence into the healthcare sector. Bipartisan US senators on Wednesday unveiled legislation aimed at increasing transparency around foreign influence in the pharmaceutical industry, amid growing concerns over US dependence on China for critical drug ingredients and medical supply chains.

US lawmakers are pushing for more scrutiny of Chinese investment in pharmaceuticals and biotechnology, as Washington’s strategic competition with Beijing expands beyond semiconductors and artificial intelligence into the healthcare sector. Bipartisan US senators on Wednesday unveiled legislation aimed at increasing transparency around foreign influence in the pharmaceutical industry, amid growing concerns over US dependence on China for critical drug ingredients and medical supply chains. “There...
Senate (ORG) US (LOCATION) China (LOCATION) Chinese (ORG) Washington (LOCATION) Beijing (LOCATION)
Originally published by South China Morning Post Read original →